Priyanka S Rana

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Multiple Myeloma

Transforming Growth Factor

Histone Deacetylase

Top Venues

Cancer research communications

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 inhibition releases HR23B to activate proteasomes, expand the tumor immunopeptidome and amplify T-cell antimyeloma activity. Cancer research communications (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J Driscoll
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial. Nature communications 15 (1) (2024)
Priyanka S Rana, James J Ignatz-Hoover, Chunna Guo, Amber L Mosley, Ehsan Malek, Yuriy Fedorov, Drew J Adams, James J Driscoll
Immunoproteasome activation expands the MHC class I immunopeptidome, unmasks neoantigens and enhances T-cell antimyeloma activity. Molecular cancer therapeutics (2024)
Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim, Ehsan Malek, Yuriy Fedorov, Drew J Adams, Timothy A Chan, James J Driscoll
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity. Cancer research communications 4 (6) (2024)
Berkha Rani, James J Ignatz-Hoover, Priyanka S Rana, James J Driscoll
Current and Emerging Strategies to Treat Urothelial Carcinoma. Cancers 15 (19) (2023)
Priyanka S Rana, Wei Wang, Vesna Markovic, Justin Szpendyk, Ernest Ricky Chan, Khalid Sossey-Alaoui
The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer. Cancer research communications 3 (1) (2023)
Priyanka S Rana, Wei Wang, Vesna Markovic, Justin Szpendyk, Ernest Ricky Chan, Khalid Sossey-Alaoui
The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer. Cancer research communications 3 (1) (2023)
Priyanka S Rana, James J Ignatz-Hoover, James J Driscoll
Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. Cancers 15 (23) (2023)